These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26938745)

  • 1. Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells.
    Duren RP; Boudreaux SP; Conneely OM
    PLoS One; 2016; 11(3):e0150450. PubMed ID: 26938745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
    Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
    Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.
    Boudreaux SP; Duren RP; Call SG; Nguyen L; Freire PR; Narayanan P; Redell MS; Conneely OM
    Leukemia; 2019 Jan; 33(1):52-63. PubMed ID: 29884904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.
    Boudreaux SP; Ramirez-Herrick AM; Duren RP; Conneely OM
    Oncogenesis; 2012 Jul; 1(7):e19. PubMed ID: 23552735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.
    Ramirez-Herrick AM; Mullican SE; Sheehan AM; Conneely OM
    Blood; 2011 Mar; 117(9):2681-90. PubMed ID: 21205929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
    Wenzl K; Troppan K; Neumeister P; Deutsch AJ
    Curr Drug Targets; 2015; 16(1):38-46. PubMed ID: 25410408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling.
    Freire PR; Conneely OM
    Blood; 2018 Mar; 131(10):1081-1093. PubMed ID: 29343483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation regulates orphan nuclear receptor NR4A1 expression in hypercholesterolaemia.
    Xie X; Song X; Yuan S; Cai H; Chen Y; Chang X; Liang B; Huang D
    Clin Sci (Lond); 2015 Dec; 129(12):1151-61. PubMed ID: 26396259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.
    Deutsch AJ; Angerer H; Fuchs TE; Neumeister P
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1001-14. PubMed ID: 22583411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.
    Veum VL; Dankel SN; Gjerde J; Nielsen HJ; Solsvik MH; Haugen C; Christensen BJ; Hoang T; Fadnes DJ; Busch C; Våge V; Sagen JV; Mellgren G
    Int J Obes (Lond); 2012 Sep; 36(9):1195-202. PubMed ID: 22143616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
    Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.
    Salzberg AC; Harris-Becker A; Popova EY; Keasey N; Loughran TP; Claxton DF; Grigoryev SA
    PLoS One; 2017; 12(3):e0173723. PubMed ID: 28301528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.
    Mohammadi M; Asgarian-Omran H; Najafi B; Najafi A; Valadan R; Karami H; Naderisoraki M; Alizadeforoutan M; Shekarriz R; Tehrani M
    Iran J Immunol; 2023 Dec; 20(4):438-445. PubMed ID: 37961948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis.
    Singh AA; Mandoli A; Prange KH; Laakso M; Martens JH
    Oncotarget; 2017 Feb; 8(8):12855-12865. PubMed ID: 28030795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
    Wu L; Amarachintha S; Xu J; Oley F; Du W
    Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.
    Roe JS; Mercan F; Rivera K; Pappin DJ; Vakoc CR
    Mol Cell; 2015 Jun; 58(6):1028-39. PubMed ID: 25982114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.
    Zhao Y; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1535-41. PubMed ID: 20631354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of Hoxa9 binding sites in hematopoietic cells.
    Huang Y; Sitwala K; Bronstein J; Sanders D; Dandekar M; Collins C; Robertson G; MacDonald J; Cezard T; Bilenky M; Thiessen N; Zhao Y; Zeng T; Hirst M; Hero A; Jones S; Hess JL
    Blood; 2012 Jan; 119(2):388-98. PubMed ID: 22072553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.